.png?key=small-avif)
Trading in KenGen PLC shares resumed late on Thursday, October 23, after the Nairobi Securities Exchange (NSE) temporarily halted activity earlier in the day following the circulation of unverified FY2025 financial results online.
- •In a statement, the NSE confirmed it had suspended trading in consultation with the Capital Markets Authority (CMA) as a precautionary measure to safeguard market integrity and protect investors from potentially misleading information.
- •The decision came after an unofficial draft of KenGen’s FY2025 audited financial results circulated widely on social media and financial news platforms.
- •KenGen later clarified that the figures were a draft version of its audited financial statements that had not yet been approved or finalized.
For real time market updates and analysis, join our WhatsApp Channel.“The decision to halt trading was made by the NSE in consultation with the Capital Markets Authority (CMA), as a precautionary measure to safeguard market integrity and protect investors from potentially misleading information.”
The exchange said in its notice.
KenGen said it is working closely with regulators to expedite the completion and publication of its FY2025 audited results within the statutory deadline. The clarification, signed by Company Secretary FCS Austin Ouko, was dated October 23, 2025.
The company urged stakeholders to rely only on official communication channels, noting that the review and approval process was still ongoing.
“It has come to our attention that a draft of the financial results has been circulated through various online platforms.”
The utility company said.
Following the official statement from KenGen, the NSE lifted the trading halt and announced that normal trading in the utility’s shares had resumed.
“Following the formal statement from KenGen clarifying that the results in question were drafts and had not been approved or finalized, the NSE has lifted the trading halt, and regular trading in KenGen shares has resumed,” the NSE confirmed.
KenGen’s clarification ends a brief episode that had unsettled investors after reports claimed the company had posted a 54% rise in profit to 10.48 Bn and declared a record dividend.